...PIK3CA, PTEN, and PIK3R1). In both cell lines and primary patient samples, we observed consistent expression patterns of...
...PIK3CA mutant breast cancers. This provides a rationale for the combined targeting of p110α with IGF1R or p110β in patie...
...PIK3CA mutations in 62 paraffinized samples of A-ACs. Of 62 A-ACs, 30.6% had KRAS mutations, but no BRAF mutations and l...
...PIK3CA), and mitogen-activated protein kinase kinase 1 (MAP2K1), whereas analysis of the STITCH-constructed network reve...
...PIK3CA) oncogenic mutations was performed as well.,Critical lymph nodes within the RAS/MAPK and PI3K/mTOR pathways were ...
...PIK3CA) (6%); cyclin D1 (CCND1) (6%); epidermal growth factor receptor (EGFR) (5%); and F-box and WD repeat domain conta...
...PIK3CA status was only found in 25 patients (42.4%, kappa =-0.141). The PIK3CA status discordance rate was significantly...
...PIK3CA mutations have provided further rational for targeted therapies. The cytokine profile in patients with ECD sugges...
...PIK3CA hotspots (in exons 9 and 20). Immunohistochemistry was performed on tissue microarray blocks prepared from sample...
...PIK3CA was present in about 20% of patients, and appeared to explain most of the reduction in colon cancer mortality by ...
联系地址
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话： 0531-88819269
版权所有 © 2025.Genelibs 济南弘晖生物技术有限公司 鲁ICP备20007159号-2
